Sign in
Taking people in United StatesPhase 2

Role of Sympathetic Overactivity and Angiotensin II in PTSD and CV

Key facts

Who runs it
Emory University
Where
Decatur, United StatesSee the site
Trial code
Status
Recruiting
Phase
Phase 2
People taking part
134 people, planned
Started
Oct 2015
Expected to end
30 Mar 2027
Type of study
Interventional, 6 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Microneurography
  • Combat virtual reality video clip
  • Handgrip Exercise
  • Cold Pressor Test (CPT)
  • Sodium Nitroprusside (SNP)
  • Phenylephrine
  • Losartan
  • Atenolol
  • Transcutaneous Vagal Nerve Stimulation (tVNS)
  • Sham Transcutaneous Vagal Nerve Stimulation (tVNS)
Record updated
18 May 2026

Who can take part

Age
18 years to 65 years
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 18 criteriaShow less

Who can take part

  • veterans ages 18-65 years old with PTSD and without PTSD (controls) matched for age, gender, and race

Who cannot take part

  • illicit drug use
  • current treatment with clonidine, beta blockers, angiotensin-converting-enzyme (ACE) inhibitors, or angiotensin II receptor blockers (ARBs)
  • treatment with monoamine oxidase (MAO) inhibitors within the last 14 days
  • hypertension
  • diabetes
  • heart or vascular disease
  • any serious systemic disease
  • heart rate < 50 beats/min
  • known hypersensitivity to ARBs or beta blockers
  • chronic kidney disease defined as estimated glomerular filtration rate (GFR) < 60 cc/min
  • hyperkalemia (serum potassium > 5 meq/dL)
  • pregnancy
  • excessive alcohol use (>2 drinks per day)
  • hyperlipidemia
  • autonomic dysfunction
  • systolic blood pressure < 100 mm Hg
  • diastolic blood pressure < 60 mm Hg

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 18 and 65 years old?

This trial is currently available in United States.

  • Atlanta VA Medical CenterDecatur, United StatesContact: Deirdre DixonTaking people

About the trial

What the trial wants to find out

The purpose of this study is to find out why patients with post-traumatic stress disorder (PTSD) have an increased risk for heart disease and high blood pressure later in life. A second purpose is to find out what causes PTSD patients to have high adrenaline levels during stress. This study will also test if a medicine called losartan improves high adrenaline levels in patients with PTSD and if a certain gene that has to do with high blood pressure might be associated with high adrenaline levels.

The 6 groups in the trial

  • Veterans with Post-traumatic Stress Disorder (PTSD)Treatment being tested

    For examining Objective 1 of this study, participants with post-traumatic stress disorder (PTSD) will be evaluated using microneurography, static handgrip exercise, cold pressor test, combat virtual reality video clip, and baroreflex sensitivity using sodium nitroprusside and phenylephrine. For the second phase, they will be randomized to either losartan or atenolol.

    Treatment: Microneurography, Combat virtual reality video clip, Handgrip Exercise, Cold Pressor Test (CPT), Sodium Nitroprusside (SNP), and Phenylephrine

  • ControlTreatment being tested

    For examining Objective 1 of this study, healthy controls will be evaluated using microneurography, static handgrip exercise, cold pressor test, combat virtual reality video clip, and baroreflex sensitivity using sodium nitroprusside and phenylephrine.

    Treatment: Microneurography, Combat virtual reality video clip, Handgrip Exercise, Cold Pressor Test (CPT), Sodium Nitroprusside (SNP), and Phenylephrine

  • LosartanTreatment being tested

    Participants with PTSD randomized to receive losartan for 8 to 14 weeks.

  • AtenololExisting treatment, for comparison

    Participants with PTSD randomized to receive atenolol for 8 to 14 weeks.

  • Transcutaneous Vagal Nerve Stimulation (tVNS)Treatment being tested

    Participants with PTSD randomized to receive treatment with tVNS for 8 to 14 weeks.

  • Sham Transcutaneous Vagal Nerve Stimulation (tVNS)Sham treatment, for comparison

    Participants with PTSD randomized to receive treatment with sham-tVNS for 8 to 14 weeks.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Post-Traumatic Stress Disorder and Cardiovascular Disease Risk: Role of Sympathetic Overactivity and Angiotensin II
Criteria questions
Built from NCT02560805, who can take part
Record updated
18 May 2026